Analabs Resources Berhad Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 3/6

Analabs Resources Berhad hat ein Gesamteigenkapital von MYR468.4M und eine Gesamtverschuldung von MYR183.0M, wodurch sich der Verschuldungsgrad auf 39.1% beläuft. Die Gesamtaktiva und Gesamtpassiva betragen MYR689.4M bzw. MYR221.0M. Analabs Resources Berhad Das EBIT des Unternehmens beträgt MYR36.9M, so dass der Zinsdeckungsgrad -295.5 beträgt. Das Unternehmen verfügt über Barmittel und kurzfristige Anlagen in Höhe von MYR20.2M.

Wichtige Informationen

39.1%

Verhältnis von Schulden zu Eigenkapital

RM 183.03m

Verschuldung

Zinsdeckungsgrad	-295.5x
Bargeld	RM 20.18m
Eigenkapital	RM 468.44m
Gesamtverbindlichkeiten	RM 220.96m
Gesamtvermögen	RM 689.40m

Jüngste Berichte zur Finanzlage

Does Analabs Resources Berhad (KLSE:ANALABS) Have A Healthy Balance Sheet?

Jan 04

Analabs Resources Berhad (KLSE:ANALABS) Has A Pretty Healthy Balance Sheet

Jan 21

Here's Why Analabs Resources Berhad (KLSE:ANALABS) Can Manage Its Debt Responsibly

Sep 13

Does Analabs Resources Berhad (KLSE:ANALABS) Have A Healthy Balance Sheet?

May 24

Does Analabs Resources Berhad (KLSE:ANALABS) Have A Healthy Balance Sheet?

Feb 09

Recent updates

Does Analabs Resources Berhad (KLSE:ANALABS) Have A Healthy Balance Sheet?

Jan 04

Analabs Resources Berhad (KLSE:ANALABS) Is Due To Pay A Dividend Of MYR0.02

Feb 13

Analabs Resources Berhad (KLSE:ANALABS) Is Doing The Right Things To Multiply Its Share Price

Mar 28

Analabs Resources Berhad (KLSE:ANALABS) Has A Pretty Healthy Balance Sheet

Jan 21

Here's Why Analabs Resources Berhad (KLSE:ANALABS) Can Manage Its Debt Responsibly

Sep 13

Does Analabs Resources Berhad (KLSE:ANALABS) Have A Healthy Balance Sheet?

May 24

Analabs Resources Berhad (KLSE:ANALABS) Might Be Having Difficulty Using Its Capital Effectively

Apr 28

Here's Why We Think Analabs Resources Berhad (KLSE:ANALABS) Is Well Worth Watching

Apr 07

Could Analabs Resources Berhad (KLSE:ANALABS) Have The Makings Of Another Dividend Aristocrat?

Mar 17

Should You Buy Analabs Resources Berhad (KLSE:ANALABS) For Its Upcoming Dividend?

Feb 19

Analyse der Finanzlage

Kurzfristige Verbindlichkeiten: ANALABSDie kurzfristigen Aktiva des Unternehmens (MYR69.5M) decken seine kurzfristigen Passiva (MYR185.9M) nicht.

Langfristige Verbindlichkeiten: ANALABSDie kurzfristigen Vermögenswerte des Unternehmens (MYR69.5M) übersteigen seine langfristigen Verbindlichkeiten (MYR35.1M).

Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Verschuldungsgrad: ANALABSDie Nettoverschuldung im Verhältnis zum Eigenkapital (34.8%) wird als zufriedenstellend angesehen.

Schulden abbauen: ANALABSDas Verhältnis von Schulden zu Eigenkapital ist in den letzten 5 Jahren von 9.9% auf 39.1% gestiegen.

Schuldendeckung: ANALABSDie Schulden des Unternehmens sind nicht ausreichend durch den operativen Cashflow (12.4%) gedeckt.

Zinsdeckung: ANALABS mehr Zinsen einnimmt als er zahlt, so dass die Deckung der Zinszahlungen kein Problem darstellt.

Analabs Resources Berhad Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 3/6

Wichtige Informationen

Jüngste Berichte zur Finanzlage

Does Analabs Resources Berhad (KLSE:ANALABS) Have A Healthy Balance Sheet?

Analabs Resources Berhad (KLSE:ANALABS) Has A Pretty Healthy Balance Sheet

Here's Why Analabs Resources Berhad (KLSE:ANALABS) Can Manage Its Debt Responsibly

Does Analabs Resources Berhad (KLSE:ANALABS) Have A Healthy Balance Sheet?

Does Analabs Resources Berhad (KLSE:ANALABS) Have A Healthy Balance Sheet?

Recent updates

First quarter 2025 earnings released: EPS: RM0.051 (vs RM0.036 in 1Q 2024)

Analabs Resources Berhad, Annual General Meeting, Oct 10, 2024

Full year 2024 earnings released: EPS: RM0.25 (vs RM0.21 in FY 2023)

Third quarter 2024 earnings released: EPS: RM0.026 (vs RM0.012 in 3Q 2023)

Analabs Resources Berhad Appoints Ling Hua Kang as Independent and Non Executive Member of Remuneration Committee

Upcoming dividend of RM0.021 per share

Analabs Resources Berhad Declares an Single Tier Interim Dividend for the Financial Year Ending 30 April 2024, Payable on 22 March 2024

Does Analabs Resources Berhad (KLSE:ANALABS) Have A Healthy Balance Sheet?

New major risk - Financial position

Analabs Resources Berhad Reports Write Offs for the Quarter Ended October 31, 2023

Analabs Resources Berhad Declares Interim Dividend for the Financial Year Ending 30 April 2024

Analabs Resources Berhad Appoints Mr. Ling Hua Kang as Independent and Non Executive Independent Director

Full year 2023 earnings released: EPS: RM0.21 (vs RM0.27 in FY 2022)

Analabs Resources Berhad, Annual General Meeting, Oct 04, 2023

Full year 2023 earnings released: EPS: RM0.21 (vs RM0.27 in FY 2022)

Third quarter 2023 earnings released: EPS: RM0.012 (vs RM0.098 in 3Q 2022)

Upcoming dividend of RM0.02 per share at 1.4% yield

Analabs Resources Berhad (KLSE:ANALABS) Is Due To Pay A Dividend Of MYR0.02

Analabs Resources Berhad Declares Interim Dividend for the Financial Year Ending 30 April 2023, Payable on 10 March 2023

Second quarter 2023 earnings released: EPS: RM0.051 (vs RM0.063 in 2Q 2022)

Analabs Resources Berhad Declares Single Tier Interim Dividend for the Financial Year Ending 30 April 2023

Analabs Resources Berhad Announces Cessation of Office of Mr. Lai Yew Choong as Independent and Non Executive Member of Risk Committee

Insufficient new directors

Analabs Resources Berhad, Annual General Meeting, Oct 05, 2022

Analabs Resources Berhad Appoints Chia Yee Yan as Independent and Non Executive Member of Audit Committee

Full year 2022 earnings released: EPS: RM0.27 (vs RM0.15 in FY 2021)

Analabs Resources Berhad Appoints Chia Yee Yan as Independent and Non Executive Director

Analabs Resources Berhad Re-Designates Kan Mun Hoow as Chief Executive Officer, Effective from 1 April 2022

Analabs Resources Berhad (KLSE:ANALABS) Is Doing The Right Things To Multiply Its Share Price

Third quarter 2022 earnings released: EPS: RM0.098 (vs RM0.051 in 3Q 2021)

Upcoming dividend of RM0.02 per share

Analabs Resources Berhad Announces Single-Tier Interim Dividend for the Period Ending April 30, 2022, Payable on March 11, 2022

Analabs Resources Berhad (KLSE:ANALABS) Has A Pretty Healthy Balance Sheet

Second quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Here's Why Analabs Resources Berhad (KLSE:ANALABS) Can Manage Its Debt Responsibly

Full year 2021 earnings released: EPS RM0.15 (vs RM0.067 in FY 2020)

Full year 2021 earnings released

Does Analabs Resources Berhad (KLSE:ANALABS) Have A Healthy Balance Sheet?

Analabs Resources Berhad (KLSE:ANALABS) Might Be Having Difficulty Using Its Capital Effectively

Here's Why We Think Analabs Resources Berhad (KLSE:ANALABS) Is Well Worth Watching

Third quarter 2021 earnings released: EPS RM0.051 (vs RM0.012 in 3Q 2020)

Could Analabs Resources Berhad (KLSE:ANALABS) Have The Makings Of Another Dividend Aristocrat?

New 90-day low: RM1.10

Should You Buy Analabs Resources Berhad (KLSE:ANALABS) For Its Upcoming Dividend?

Does Analabs Resources Berhad (KLSE:ANALABS) Have A Healthy Balance Sheet?

New 90-day high: RM1.19

Is Analabs Resources Berhad (KLSE:ANALABS) Set To Make A Turnaround?

Second quarter 2021 earnings released: EPS RM0.022

Is Analabs Resources Berhad (KLSE:ANALABS) An Attractive Dividend Stock?

New 90-day high: RM1.22

Analabs Resources Berhad Announces the Resignation of TAN AI PENG as Company Secretary

First quarter earnings released

Full year earnings released - EPS RM0.067

Analyse der Finanzlage

Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Bilanz

Entdecken Sie finanziell stabile Unternehmen